Resveratrol, a polyphenolic compound found in red grapes and berries, has attracted considerable interest for its potential anti-ageing properties. Whilst laboratory studies suggest mechanisms involving cellular metabolism and antioxidant activity, the evidence for resveratrol dosage for anti-ageing in humans remains limited and inconclusive. In the UK and EU, trans-resveratrol is authorised as a novel food ingredient with a maximum daily intake of 150 mg for adults. It is crucial to understand that no UK regulatory bodies—including NICE, the MHRA, or NHS—have established resveratrol as a proven anti-ageing intervention. This article examines the current evidence, recommended dosages, safety considerations, and practical guidance for those considering resveratrol supplementation.

What Is Resveratrol and How Does It Work for Anti-Ageing?

Resveratrol is a naturally occurring polyphenolic compound found predominantly in the skins of red grapes, berries, and certain nuts. It belongs to a class of plant compounds called stilbenes, which are produced by plants in response to stress, injury, or fungal infection. Resveratrol gained scientific attention following observations of the 'French paradox'—a historical observation of relatively low incidence of cardiovascular disease in populations consuming red wine despite high saturated fat intake, though this association does not prove causality.

At the cellular level, resveratrol has been studied for potential anti-ageing effects through several mechanisms. Research suggests it may influence a family of proteins called sirtuins, particularly SIRT1, which are regulators of cellular metabolism and stress responses. However, it's important to note that direct SIRT1 effects by resveratrol remain debated, with most evidence coming from laboratory and animal studies. Additionally, resveratrol demonstrates antioxidant properties in experimental settings, potentially helping to neutralise free radicals that contribute to oxidative stress and cellular damage.

Laboratory studies suggest resveratrol may influence mitochondrial function, the energy-producing structures within cells that decline with age. By potentially supporting mitochondrial efficiency, resveratrol could theoretically help maintain cellular energy levels. Furthermore, it appears to modulate inflammatory pathways in preclinical models.

It is crucial to understand that these mechanisms are primarily observed in laboratory and animal studies, with uncertain translation to humans at typical supplement doses. There is no official link established by UK regulatory bodies such as the MHRA, NICE or NHS between resveratrol supplementation and proven anti-ageing effects in humans. The European Food Safety Authority (EFSA) has not approved any health claims related to resveratrol and anti-ageing.

Recommended Resveratrol Dosage for Anti-Ageing Benefits

There is currently no officially established therapeutic dose of resveratrol for anti-ageing purposes, as it is not licensed as a medicine in the UK for this indication. Resveratrol supplements are classified as food supplements and are not subject to the same rigorous efficacy standards as pharmaceutical products.

Important regulatory context: In the UK and EU, trans-resveratrol is authorised as a novel food ingredient with a maximum daily intake limit of 150 mg per day for adults. This supplement is not authorised for use by pregnant or breastfeeding women. This limit has been established based on safety assessments by the European Food Safety Authority (EFSA) and is reflected in the Food Standards Agency (FSA) list of authorised novel foods in Great Britain.

Whilst some research studies have used higher doses ranging from 150 mg to 2,000 mg daily, these were conducted under medical supervision in controlled settings. Such doses exceed the authorised daily intake and should not be self-administered without clinical oversight.

It is important to recognise that bioavailability—the proportion of resveratrol that enters the bloodstream and reaches target tissues—is relatively poor. Resveratrol undergoes extensive first-pass metabolism in the liver and intestine, meaning that much of an oral dose is rapidly converted to metabolites before reaching systemic circulation.

For individuals considering resveratrol supplementation, it is advisable to:

• Not exceed the authorised daily intake of 150 mg without medical supervision

• Choose products from reputable manufacturers with third-party testing

• Consult a GP or pharmacist, particularly if taking other medications

• Be aware that higher doses may be associated with liver enzyme elevations in some individuals

Patients should be aware that resveratrol is not a substitute for evidence-based interventions such as smoking cessation, regular physical activity, and a balanced diet—all of which have robust evidence for promoting healthy ageing.

Evidence for Resveratrol in Skin and Cellular Ageing

The evidence base for resveratrol's anti-ageing effects in humans remains limited and largely preliminary. Whilst laboratory studies and animal models have demonstrated promising results, clinical trials in humans have produced mixed and often modest findings. It is crucial to distinguish between mechanistic plausibility and proven clinical benefit.

In terms of cellular ageing, some human studies have shown that resveratrol supplementation may influence biomarkers associated with ageing. A small number of trials have reported improvements in markers of oxidative stress, inflammation, and endothelial function—factors implicated in cardiovascular ageing. However, these studies typically involved small sample sizes, short durations, and varied methodologies, limiting the strength of conclusions that can be drawn.

Regarding skin ageing, the evidence is even more preliminary. Some in vitro studies suggest that resveratrol may protect skin cells from ultraviolet radiation damage and support collagen synthesis. A limited number of small trials examining topical resveratrol formulations have reported improvements in skin texture and reduction in fine lines, but these findings require replication in larger, well-controlled studies. Publication bias—where positive results are more likely to be published than negative ones—is also a consideration in this field. Oral supplementation for skin health has been less extensively studied, and there is insufficient evidence to confirm meaningful benefits.

Systematic reviews of resveratrol's effects on human health have concluded that whilst some metabolic benefits may exist, particularly in individuals with metabolic syndrome, the evidence for general anti-ageing effects remains inconclusive. The European Food Safety Authority (EFSA) has not approved any health claims related to resveratrol and anti-ageing.

Patients should be counselled that:

• Current evidence does not support resveratrol as a proven anti-ageing intervention

• No UK health authorities (NICE, MHRA, NHS) recommend resveratrol for anti-ageing

• Lifestyle factors (sun protection, smoking cessation, nutrition) have stronger evidence for skin health

• Further high-quality research is needed before definitive recommendations can be made

Safety Considerations and Potential Side Effects

Resveratrol is generally considered well-tolerated at the authorised novel food intake level (150 mg daily), with most reported adverse effects being mild and transient. However, as with any supplement, there are important safety considerations that healthcare professionals and patients should be aware of.

Common side effects reported in clinical trials include:

• Gastrointestinal disturbances (nausea, diarrhoea, abdominal discomfort)

• Headache

• Dizziness

• Fatigue

These effects are typically dose-dependent and more likely to occur at higher doses. In most cases, symptoms resolve with dose reduction or discontinuation. Some studies using higher doses have reported mild elevations in liver enzymes (ALT/AST), suggesting potential hepatic effects that warrant caution with prolonged use above authorised levels.

A significant concern relates to drug interactions. Resveratrol may have antiplatelet effects, potentially increasing bleeding risk when combined with:

• Anticoagulants (such as warfarin, apixaban, rivaroxaban, dabigatran)

• Antiplatelet agents (such as aspirin, clopidogrel)

• NSAIDs (such as ibuprofen, naproxen)

Patients taking these medications should consult their GP before starting resveratrol supplementation. Additionally, resveratrol may interact with certain cytochrome P450 enzymes involved in drug metabolism, potentially affecting the efficacy or safety of other medications, though most interaction data comes from laboratory rather than human studies.

Contraindications and precautions include:

• Pregnancy and breastfeeding (not authorised for use)

• Bleeding disorders or upcoming surgery (discontinue 1-2 weeks before procedures)

• Hormone-sensitive conditions (due to potential oestrogenic effects)

• Children and adolescents (no established safety profile)

• Liver conditions (due to potential enzyme elevations at higher doses)

Product quality varies considerably between manufacturers. Some resveratrol supplements derived from Japanese knotweed (Polygonum cuspidatum) may contain contaminants such as emodin or heavy metals. Choose products with independent quality testing.

Patients should contact their GP if they experience persistent gastrointestinal symptoms, unusual bleeding or bruising, or any concerning symptoms after starting resveratrol. Suspected adverse reactions to supplements should be reported through the MHRA Yellow Card Scheme.

How to Take Resveratrol: Timing and Absorption Tips

Optimising resveratrol absorption is important given its inherently poor bioavailability. Whilst there are no official NHS or NICE guidelines on resveratrol administration, research findings and pharmacological principles can inform practical recommendations.

Timing of administration may influence absorption and effects. Some evidence suggests that resveratrol absorption may be enhanced when taken with food, particularly meals containing some fat, as resveratrol is lipophilic (fat-soluble). However, human data are limited, and other studies indicate that food may slow absorption without necessarily increasing total bioavailability. A pragmatic approach is to take resveratrol with a meal to minimise gastrointestinal side effects, which are more common on an empty stomach.

Regarding formulation, several strategies have been developed to potentially enhance bioavailability:

• Micronised formulations: Smaller particle sizes may improve dissolution and absorption

• Liposomal preparations: Encapsulation in lipid vesicles may protect resveratrol from degradation

• Trans-resveratrol: This is the active isomer; supplements should specify trans-resveratrol content

The timing during the day is less critical from an evidence-based perspective. Consistency in timing may help maintain steady-state levels.

Practical recommendations for patients include:

• Do not exceed the authorised daily intake of 150 mg without medical supervision

• Take with a meal to reduce gastrointestinal upset

• Choose supplements specifying standardised trans-resveratrol content from reputable manufacturers

• Store in a cool, dark place to prevent degradation

• Avoid taking with grapefruit juice, which may unpredictably affect metabolism

• Maintain realistic expectations regarding benefits

It is worth emphasising that dietary sources of resveratrol—such as red grapes, blueberries, and peanuts—provide additional beneficial compounds (flavonoids, fibre) that supplements lack. A varied, plant-rich diet remains the foundation of evidence-based nutritional approaches to healthy ageing, with supplementation as a potential adjunct rather than replacement.

Frequently Asked Questions